SCHEMBL5507634

SCHEMBL5507634

C#CC1O[C@@H](n2cnc3c(NC4CCC4)ncnc32)[C@H](O)[C@@H]1O

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 4/20 0.67
TSHR P16473 3/20 0.67
ADORA2B P29275 3/20 0.67
ADORA3 P0DMS8 3/20 0.67
PMP22 Q01453 2/20 0.67
ADORA1 P30542 2/20 0.67
GAA P10253 1/20 0.67
HTT P42858 1/20 0.67
SIGMAR1 Q99720 1/20 0.67
SLC29A1 Q99808 1/20 0.67
RXFP1 Q9HBX9 1/20 0.67
MEN1 O00255 1/20 0.67
KMT2A Q03164 1/20 0.67
TP53 P04637 1/20 0.67
NFKB1 P19838 1/20 0.67
HIF1A Q16665 1/20 0.67
SMN1; SMN2 Q16637 1/20 0.66
TDP1 Q9NUW8 1/20 0.66
CYP2C19 P33261 1/20 0.66
THPO P40225 1/20 0.66

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5992981 1.00 ADORA2A (0.67) ADORA2ATSHRADORA2BADORA3PMP22
SCHEMBL5507638 1.00 ADORA2A (0.67) ADORA2ATSHRADORA2BADORA3PMP22
SCHEMBL5504529 0.98 ADORA2A (0.70) ADORA2ATSHRADORA2BADORA3PMP22
SCHEMBL5510434 0.97 ADORA2A (0.70) ADORA2ATSHRADORA2BADORA3PMP22
SCHEMBL6266706 0.96 AHCY (0.65) ADORA2ATSHRADORA2BADORA3PMP22
SCHEMBL6259026 0.96 AHCY (0.65) ADORA2ATSHRADORA2BADORA3PMP22
SCHEMBL6257699 0.93 AHCY (0.62) ADORA2ATSHRADORA2BADORA3PMP22
SCHEMBL6256707 0.93 AHCY (0.62) ADORA2ATSHRADORA2BADORA3PMP22
SCHEMBL6257614 0.92 ADORA2A (0.69) ADORA2ATSHRADORA2BADORA3PMP22
SCHEMBL5506309 0.90 ADORA1 (0.64) ADORA2ATSHRADORA2BADORA3PMP22

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1537133-B1 PARTIAL AND FULL AGONISTS OF A1 ADENOSINE RECEPTORS CV THERAPEUTICS INC (US) 2007-07-25 EP disclosed